Kidney injury molecule-1 expression in murine polycystic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 6 52-6, 2002, Pages

  Kuehn, E Wolfgang ^a   Park, Kwon Moo ^a   Somlo, Stefan ^b   Bonventre, Joseph V ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell polarity; Fibrosis; Ischemia; Kidney obstruction; Na K ATPase; Tim

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA ACTIN; MEMBRANE PROTEIN; POLYCYSTIN; PROTEIN KIM 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BASOLATERAL MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; KIDNEY EPITHELIUM; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036890193     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00166.2002     Document Type: Article

References (34)

1. Arystarkhova E and Sweadner KJ. Isoform-specific monoclonal antibodies to Na,K-ATPase alpha subunits. Evidence for a tissue-specific posttranslational modification of the alpha subunit. J Biol Chem 271: 23407-23417, 1996.
2. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, and Bonventre JV. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem In press.
3. Brown D, Lee R, and Bonventre JV. Redistribution of villin to proximal tubule basolateral membranes after ischemia and reperfusion. Am J Physiol Renal Physiol 273: F1003-F1012, 1997.
4. Bush KT, Tsukamoto T, and Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 278: F847-F852, 2000.
5. Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, Mochizuki T, Park JH, Witzgall R, and Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 274: 28557-28565, 1999.
6. Chapman AB, Johnson A, Gabow PA, and Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323: 1091-1096, 1990.
7. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000.
8. 2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 98: 11821187, 2001.
9. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F, and Schena FP. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 7: 906-913, 1996.
10. Han WK, Bailly V, Abichandani R, Thadhani R, and Bonventre JV. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244, 2002.
11. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
12. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, and Germino GG. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408: 990-994, 2000.
13. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, and Sanicola M. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998.
14. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, Ehrlich BE, and Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4: 191-197, 2002.
15. Lennon G, Auffray C, Polymeropoulos M, and Soares MB. The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression. Genomics 33: 151-152, 1996.
16. McIntire JJ, Umetsu SE, Akbari O, Potter M, Kuchroo VK, Barsh GS, Freeman GJ, Umetsu DT, and DeKruyff RH. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immun 2: 1109-1116, 2001.
17. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, and Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996.
18. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, and Kuchroo VK. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541, 2002.
19. Nadasdy T, Laszik Z, Lajoie G, Bliek KE, Wheeler DE, and Silva FG. Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 5: 1462-1468, 1995.
20. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, and Neilson EG. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation. Kidney Int 58: 587-597, 2000.
21. Park KM, Kramers C, Vayssier-Taussat M, Chen A, and Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 277: 2040-2049, 2002.
22. Ramasubbu K, Gretz N, and Bachmann S. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol 9: 937-945, 1998.
23. Roberts IS, Burrows C, Shanks JH, Venning M, and McWilliam LJ. Interstitial myofibroblasts: Predictors of progression in membranous nephropathy. J Clin Pathol 50: 123-127, 1997.
24. Sabolic I, Valenti G, Verbavatz JM, Van Hoek AN, Verkman AS, Ausiello DA, and Brown D. Localization of the CHIP28 water channel in rat kidney. Am J Physiol Cell Physiol 263: C1225-C1233, 1992.
25. Somlo S and Markowitz GS. The pathogenesis of autosomal dominant polycystic kidney disease: An update. Curr Opin Nephrol Hypertens 9: 385-394, 2000.
26. Tanner GA, Gretz N, Connors BA, Evan AP, and Steinhausen M. Role of obstruction in autosomal dominant polycystic kidney disease in rats. Kidney Int 50: 873-886, 1996.
27. Tesch GH, Maifert S, Schwarting A, Rollins BJ, and Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRLFas(1pr) mice. J Exp Med 190: 1813-1824, 1999.
28. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Grone HJ, and Schlondorff D. Obstructive nephropathy in the mouse: Progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12: 1173-1187, 2001.
29. Wagner MC and Molitoris BA. Renal epithelial polarity in health and disease. Pediatr Nephrol 13: 163-170, 1999.
30. Wang SN and Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Physiol 278: F554-F560, 2000.
31. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333: 18-25, 1995.
32. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H Jr, Kucherlapati R, Edelmann W, and Somlo S. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93: 177-188, 1998.
33. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, and Ritz E. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 42: 1259-1265, 1992.
34. Zuk A, Bonventre JV, Brown D, and Matlin KS. Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney. Am J Physiol Cell Physiol 275: C711-C731, 1998.